Interestingly, molecular studies have demonstrated that SFN considerably inhibits the survival of MCF-7, MDA-MB-231, MDA-MB-238, and SKBR-3 breast cancer cells in a dose-dependent manner, seemingly through attenuation of phosphorylation of Akt and S6K1 [70]. Here, AKT1 is linked to breast cancer.